(S)-Methyl 3-(4-hydroxyphenyl)hex-4-ynoate, 97%, 500mg

Bis(4-methoxybenzyl)amine, 98%, 25g

6-((tetrahydrofuran-3-yl)oxy)nicotinic acid, 95.0%, 250mg

2-Isobutyl-3,5,6-trimethylpyrazine, 95.0%, 250mg

4-bromo-2-{[(1-propyl-1H-benzimidazol-2-yl)amino]methyl}phenol, 95.0%, 1g

8-Bromo-4-hydroxyquinolin-2(1H)-one, ��97.0%, 250mg

(1R,3S)-3-((tert-butoxycarbonyl)amino)cyclopentyl acetate compound with (1S,3R)-3-((tert-butoxycarbonyl)amino)cyclopentyl acetate, 98%, 10g

(R)-2-Amino-3-(o-tolyl)propanoic acid, 95.0%, 5g

1-Methylimidazole>99.0%(GC)25g

Pyrrolidine-2,5-diyldimethanol, 95.0%, 1g

4,4,5,5-Tetramethyl-2-(3,4,5-trifluorophenyl)-1,3,2-dioxaborolane>98.0%(GC)(T)1g

2,6-Dichloro-4-isopropylnicotinonitrile, 97%, 5g

6-Tosyl-2-oxa-6-azaspiro[3.3]heptane, 95.0%, 25g